I. Homa

The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients

P. Krawczyk, J. Milanowski, M. Prendecka, 2016, Clinical and Translational Oncology.

Rare co-existence of mutation in KRAS and ALK gene re-arrangement in an adenocarcinoma patient--a case report.

P. Krawczyk, J. Milanowski, E. Czekajska-Chehab, 2014, Anticancer research.

The impact of ACE gene polymorphism on the incidence and phenotype of sarcoidosis in rural and urban settings

M. Szczyrek, P. Krawczyk, J. Milanowski, 2015, Archives of medical science : AMS.

Predictive value of ERCC1 and RRM1 gene single-nucleotide polymorphisms for first-line platinum- and gemcitabine-based chemotherapy in non-small cell lung cancer patients.

P. Krawczyk, J. Milanowski, R. Ramlau, 2013, Oncology reports.

Predictive value of ERCC 1 and RRM 1 gene single-nucleotide polymorphisms for first-line platinum-and gemcitabine-based chemotherapy in non-small cell lung cancer patients

P. Krawczyk, J. Milanowski, R. Ramlau, 2013 .

Predictive value of STMN1 gene promoter polymorphism (−2166T>C) in patients with advanced NSCLC treated with the combination of platinum compounds and vinorelbine

P. Krawczyk, J. Milanowski, M. Prendecka, 2015, Cancer Chemotherapy and Pharmacology.

The relationship between RRM1 gene polymorphisms and effectiveness of gemcitabine-based first-line chemotherapy in advanced NSCLC patient

P. Krawczyk, J. Milanowski, M. Prendecka, 2015, Clinical and Translational Oncology.